Alimera Sciences Inc (NAS:ALIM)
$ 5.54 -0.01 (-0.18%) Market Cap: 301.29 Mil Enterprise Value: 360.44 Mil PE Ratio: 0 PB Ratio: 7.49 GF Score: 41/100

Alimera Sciences Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) Transcript

Feb 09, 2022 / 03:00PM GMT
Release Date Price: $4.56 (+0.22%)
Operator

Good day, and welcome to the Second Annual Winter Wonderland Best Ideas Conference. The next presenting company is Alimera Sciences. (Operator Instructions)

I'd now like to turn the floor over to today's host, Rick Eiswirth, President and CEO of Alimera Sciences. Sir, the floor is yours.

Richard S. Eiswirth
Alimera Sciences, Inc. - President, CEO & Director

Great. Thank you very much, and thank you all for joining me today. As our opening slide sits here today, the focus for Alimera is retina disease. We think there's a unique opportunity here to build a special company based on built around retina specialists and their patients. I think there's unique opportunity there because, frankly, no one else is doing it. There's only about 10 or 11 products that have ever been approved for the retina. And most of those products are a single product in a much bigger company that is focused outside the eye. And so that retina specialist doesn't get the focus of the company.

To give you an example, sort of the standard of care in retina disease is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot